Docebo (DCBO) Tender Offer at $20.40: A 10% Premium Issuer Bid

Docebo's $60 Million Issuer Bid: Buying Back Shares at $20.40

Docebo Inc. (NASDAQ/TSX: DCBO) has launched a substantial issuer bid to repurchase up to US$60 million of its own common shares at a fixed price of US$20.40 per share. This is not an acquisition by a third party—it is a self-tender, where the company itself is buying back stock. Because Docebo is incorporated in Canada, this tender offer carries cross-border tax consequences that can eat most of the apparent spread for U.S. investors in taxable accounts.

Company Background

Docebo is a Toronto-headquartered AI-powered LMS company (NASDAQ/TSX: DCBO) with approximately US$243 million in annual revenue and US$74 million in cash. It is incorporated in Canada, which has significant tax implications for this tender offer.

Full-year 2025 net income was US$37.5 million and free cash flow was US$38.4 million.

Deal Overview

Docebo is offering to purchase up to 2,941,176 of its common shares at US$20.40 per share, for a maximum outlay of US$60,000,000. The company filed its initial Schedule 13E-4F with the SEC on February 3, 2026, followed by Amendment No. 1 on February 25, 2026, which disclosed Intercap Equity's potential participation.

Docebo plans to fund the offer with approximately US$30 million in cash on hand and a roughly US$30 million draw on its revolving credit facility. To support the transaction, the company doubled its credit facility from US$50 million to US$100 million. This marks a shift for a company that had been essentially debt-free.

As of February 1, 2026, there were 28,757,629 common shares outstanding. The 2,941,176 shares sought represent approximately 10.23% of total shares on a non-diluted basis.

Key Terms

• Offer price: US$20.40 per common share, payable in cash
• Maximum aggregate purchase price: US$60,000,000
• Maximum shares to be purchased: 2,941,176 (approximately 10.23% of outstanding)
• Expiration date: March 10, 2026 at 5:00 p.m. Eastern time (subject to extension)
• Minimum tender condition: none—the offer proceeds even if a single share is tendered
• Proration: if more than 2,941,176 shares are tendered, purchases are prorated among tendering holders
• Odd-lot preference: holders of fewer than 100 shares who tender all shares are exempt from proration
• Withdrawal rights: shares may be withdrawn at any time before the company takes them up
• Dealer manager: Canaccord Genuity Corp.
• Depositary: TSX Trust Company

Market Context

• Pre-announcement close (January 28, 2026): US$18.52 on Nasdaq
• Offer price: US$20.40
• Premium to pre-announcement price: 10.2%
• Current trading price: US$19.03
• Premium to current price: 7.2%
• 52-week range: US$16.20–US$33.16 (Nasdaq)

At US$19.03, the stock has risen from its 52-week lows. The 7.2% gross spread looks attractive on paper—but as detailed below, Canadian withholding tax now exceeds the spread in a taxable account.

Timeline

The Intercap Factor

Intercap Equity Inc., the Toronto-based merchant bank controlled by Jason Chapnik (who chairs Docebo's board), beneficially owns approximately 56.6% of Docebo's outstanding shares. In the original filing, Intercap stated it did not intend to tender, which would have passively increased its ownership percentage as other shares were retired. On February 18, Intercap reversed course, disclosing it may now tender shares "with the goal of maintaining its approximate current ownership interest in the Company."

This dramatically increases proration risk. If Intercap tenders proportionally to maintain its 56.6% stake, it would tender roughly 1.66 million of the 2.94 million shares being sought—filling over half the offer with its own shares and shrinking the allocation available to everyone else.

Proration Analysis: What 1,000 Shares Looks Like

Docebo's 2023 issuer bid is the key precedent: that US$100 million offer at US$55.00 per share resulted in a proration factor of only 6.77% for non-odd-lot holders, driven largely by Intercap tendering.

The table below models three scenarios for a holder tendering 1,000 shares at the current spread (buy at US$19.03, tender at US$20.40, gross spread of US$1.37/share). Canadian withholding tax is estimated at US$1.86 per share (see the tax section below). Scenarios are ordered worst-case first.

Assumptions: proration factor = 2,941,176 / total tendered (scenarios 2–4). Scenario 1 uses the actual 6.7% proration from Docebo's 2023 issuer bid, where odd-lot holders were filled first, reducing the pool available to larger holders. Net spread = (accepted shares x US$1.37) - (accepted shares x US$1.86). Non-accepted shares are returned and remain subject to market risk. In each scenario, the investor's remaining 820–933 shares are not purchased and must be sold at prevailing market prices.

The real risk is what happens to the unaccepted shares: if the stock drops after the offer closes and the NCIB buying support remains suspended, losses on returned shares could easily exceed the tendering gain. The 2023 bid's 6.77% proration is a cautionary data point.

The Odd-Lot Opportunity

Odd-lot holders—those owning fewer than 100 shares—who tender all of their shares are purchased in full before proration is applied to larger holders. This is the cleanest trade available, but the Canadian withholding tax still bites.

The WHT is not necessarily a permanent loss—U.S. taxpayers can generally claim a foreign tax credit on their federal return, which may recover most or all of the US$184. Usability depends on your individual tax situation.

The Roth IRA angle deserves attention. Under the U.S.-Canada tax treaty, distributions from a Roth IRA are generally exempt from Canadian tax. If your custodian properly applies the treaty exemption, the full US$136 gross profit could flow through without withholding. Broker policies vary—contact your custodian before relying on the exemption.

Canadian Tax Treatment: The Deemed Dividend

This is the single most important feature distinguishing Docebo's issuer bid from a typical U.S. tender offer.

Under Section 84(3) of the Income Tax Act (Canada), when a Canadian corporation purchases its own shares, the excess of the purchase price over the paid-up capital (PUC) is treated as a deemed dividend—not a capital gain—for Canadian tax purposes, regardless of where the shareholder resides.

The Math Per Share

The 15% rate applies to U.S. residents who qualify under the U.S.-Canada tax treaty. Without the treaty, the statutory rate is 25%. Brokers withhold automatically at the time of payment.

Impact on the Spread

The gross spread at current prices is US$1.37 per share (US$20.40 minus US$19.03). After the estimated US$1.86 per share in Canadian withholding, the net spread is approximately −US$0.49 per share. The withholding tax now exceeds the gross spread — this is the dominant feature of the risk/reward calculus.

Capital Gain Component

For U.S. tax purposes, only the PUC portion (~US$8.03 per share) is treated as proceeds of disposition. If your cost basis exceeds US$8.03, the transaction may generate a capital loss on your U.S. return—even though you received more cash than you paid for the shares.

Roth IRA Exemption

Article XVIII(7) of the U.S.-Canada tax treaty provides that Canadian tax on income accrued in a Roth IRA may be deferred or exempt. If the exemption applies, no Canadian withholding tax would be deducted and the full gross spread would be captured. This makes the Roth IRA the most attractive account type for this trade—but enforcement depends on your broker filing the correct treaty forms.

PFIC Warning

If Docebo qualifies as a passive foreign investment company (PFIC), U.S. holders could face additional tax and interest charges on the deemed dividend. Docebo has not made a definitive PFIC determination. Consult a tax advisor before tendering.

Post-Tender Outlook

Assuming full repurchase, the share count would fall to approximately 25.8 million. On fiscal 2025 net income of US$37.5 million, EPS would accrete from roughly US$1.30 to US$1.45—an 11–12% boost. The tradeoff: the company will have deployed ~US$30 million in cash and drawn ~US$30 million on its credit facility, leaving ~US$44 million in cash with new debt on a previously clean balance sheet.

The NCIB has been suspended and cannot resume until at least 20 business days after the offer concludes (approximately April 7, 2026). During this gap, the stock loses one source of buying support. After the 2023 issuer bid (6.77% proration), the stock traded lower in the weeks following.

The Spread

With DCBO trading at US$19.03 and the offer price at US$20.40, the gross spread is US$1.37 per share, or 7.2%. After estimated Canadian withholding tax of US$1.86 per share, the net spread is approximately −US$0.49 — the WHT now exceeds the gross spread.

The risk/reward breaks down along account type:

• Taxable account, odd lot (fewer than 100 shares): −2.6% net return after WHT. The WHT is recoverable via foreign tax credit on your U.S. return, which would restore the full 7.2% gross spread — but that recovery depends on your individual tax situation. No proration risk.
• Roth IRA, odd lot: if the treaty exemption is honored by your broker, the full ~7% gross spread is captured with no proration risk. This is the best-case scenario.
• Taxable account, larger position: negative net spread on accepted shares after WHT, proration risk on the rest, and market risk on returned shares. The 2023 bid saw only 6.77% of non-odd-lot shares accepted.

The offer expires March 10, 2026. Internal broker deadlines may be several days earlier—check with your broker for the actual cutoff.

Amendment: Offer Results (March 11, 2026)